Press "Enter" to skip to content

New patent for Keryx Biopharms drug AURYXIA

0
Copyright © DrugPatentWatch. Originally published at New patent for Keryx Biopharms drug AURYXIA

Annual Drug Patent Expirations for AURYXIA
Annual Drug Patent Expirations for AURYXIA

Auryxia is a drug marketed by Keryx Biopharms and is included in one NDA. It is available from one supplier. There are fifteen patents protecting this drug.

AURYXIA drug price trends.

Drug patent litigation for AURYXIA.

This drug has one hundred and twenty-five patent family members in twenty-six countries.

The generic ingredient in AURYXIA is ferric citrate. One supplier is listed for this compound. Additional details are available on the ferric citrate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent for Keryx Biopharms drug AURYXIA
    Get the DrugPatentWatch Daily Briefing

    ✓ Patent Expirations and Generic Entry

    ✓ Insightful Articles & Case Studies

    ✓ Patent Litigation & Challenges

    ✓ 505(b)(2) & Biosimilars

    ✓ Industry Trends

    Do NOT follow this link or you will be banned from the site!